Pulse Biosciences (PLSE)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
Fundamental grade
Five factors scored 1 to 9 from PLSE's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from Pulse Biosciences's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $1M | $700,000 | $0 | $0 | $350,000 |
| Net income | -$64M | -$59M | -$42M | -$54M | -$73M |
| Free cash flow | -$55M | -$47M | -$33M | -$36M | -$54M |
| EPS (diluted) | -$2.28 | -$1.72 | -$0.85 | -$0.92 | -$1.08 |
| Operating margin | -4443.9% | -8293.9% | — | — | -21982.6% |
Where the revenue comes from
Revenue by products, fiscal 2022. Every breakdown, year by year.
Superinvestors who own PLSE
From each investor's latest 13F filing (what a 13F shows). 1 of the investors we track hold it.
| Investor | Last quarter | Value | % of portfolio | Quarter |
|---|---|---|---|---|
| Cliff Asness AQR Capital Management |
New position | $237,535 | 0.0% | Q2 2026 |
Insider buying
Open-market purchases by Pulse Biosciences's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you. Every purchase since records began.
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Sep 1, 2026 | Liane Rae Teplitsky Chief Operating Officer |
1,001 | $49.95 | $50,000 |
| Aug 31, 2026 | Liane Rae Teplitsky Chief Operating Officer |
1,024 | $48.80 | $49,971 |
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when PLSE trades at or below it.
New accounts get 7 days of Pro, price alerts included. No card needed.
In the full deep dive
Questions
Are Pulse Biosciences insiders buying the stock?
2 open-market insider purchases of PLSE in the last 12 months, from SEC Form 4 filings.
Which superinvestors own Pulse Biosciences?
1 of the superinvestors Investingly tracks hold PLSE in their latest 13F, including Cliff Asness.
Companies like Pulse Biosciences
All Healthcare stocks · Medical Instruments & Supplies stocks · Stock lists
Prices and ratios as of Oct 8, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.